Researchers at St. Jude have identified a set of twenty two markers that predicts minimal residual disease in B-lineage acute lymphoblastic leukemia (ALL) patients. MRD detection by flow cytometry wi
[更多]
None
[更多]
Researchers from the Monash Institute of Pharmaceutical Sciences and collaborators, have identified novel peptides that are highly potent and selective inhibitors of the Kv1.3 potassium channel.
[更多]
 |
None
[更多]
Does not contain xenobiotics: Eliminates risk of transmitting animal disease to recipientDoes not use cholera toxin or DMSO (to enhance membrane permeability)
[更多]
| |< <- | [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] | -> >| |
